1. Home
  2. SHO vs NTLA Comparison

SHO vs NTLA Comparison

Compare SHO & NTLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHO

Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

HOLD

Current Price

$11.36

Market Cap

1.8B

ML Signal

HOLD

Logo Intellia Therapeutics Inc.

NTLA

Intellia Therapeutics Inc.

HOLD

Current Price

$17.38

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHO
NTLA
Founded
1995
2014
Country
United States
United States
Employees
37
N/A
Industry
Hotels/Resorts
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.8B
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
SHO
NTLA
Price
$11.36
$17.38
Analyst Decision
Hold
Buy
Analyst Count
7
23
Target Price
$9.79
$20.02
AVG Volume (30 Days)
3.1M
6.7M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
3.66%
N/A
EPS Growth
N/A
27.43
EPS
N/A
N/A
Revenue
N/A
$67,671,000.00
Revenue This Year
$3.95
N/A
Revenue Next Year
$2.30
$62.75
P/E Ratio
$966.33
N/A
Revenue Growth
N/A
16.92
52 Week Low
$8.52
$7.95
52 Week High
$12.07
$28.24

Technical Indicators

Market Signals
Indicator
SHO
NTLA
Relative Strength Index (RSI) 49.80 69.19
Support Level $8.81 $11.73
Resistance Level $12.07 $27.61
Average True Range (ATR) 0.26 1.21
MACD -0.11 0.28
Stochastic Oscillator 23.04 84.38

Price Performance

Historical Comparison
SHO
NTLA

About SHO Sunstone Hotel Investors Inc. Sunstone Hotel Investors Inc.

Sunstone Hotel Investors Inc is a real estate investment trust that acquires, owns, manages, and renovates the full-service hotel and select-service hotel properties across various states in the United States. Its firm's portfolio consists upper upscale and luxury hotels located in convention, resort destination and urban markets. Its majority of the hotels operate under a brand owned by Marriott, Hilton, Hyatt, Four Seasons or Montage. It operates geographically in California which generates the majority of its revenue; Florida; and Hawaii. The company's sole source of income is hotel revenue from its Hotel Ownership Segment.

About NTLA Intellia Therapeutics Inc.

Intellia Therapeutics is a gene-editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. Intellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple gene editing approaches using in vivo and ex vivo therapies to address diseases with high unmet medical needs, including ATTR amyloidosis, hereditary angioedema, sickle cell disease, and immuno-oncology. Intellia has formed collaborations with several companies to advance its pipeline, including narrow-moat Regeneron and wide-moat Novartis.

Share on Social Networks: